| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | BUY | BUY | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 76.52▼ | 76.79▼ | 76.71▼ | 75.15▲ | 76.29▼ |
| MA10 | 76.69▼ | 76.78▼ | 76.36▼ | 74.68▲ | 78.93▼ |
| MA20 | 76.88▼ | 76.30▼ | 75.62▲ | 75.92▲ | 80.49▼ |
| MA50 | 76.85▼ | 75.38▲ | 74.94▲ | 79.08▼ | 77.81▼ |
| MA100 | 76.25▼ | 74.85▲ | 74.75▲ | 80.45▼ | 77.74▼ |
| MA200 | 75.50▲ | 75.08▲ | 76.60▼ | 80.27▼ | 90.46▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.094▼ | -0.058▼ | 0.085▲ | 0.304▲ | -1.016▼ |
| RSI | 24.584▼ | 49.956▼ | 56.841▲ | 48.388▼ | 45.994▼ |
| STOCH | 5.716▼ | 55.923 | 76.019 | 67.251 | 23.443 |
| WILL %R | -96.667▼ | -65.951 | -44.699 | -35.423 | -72.895 |
| CCI | -219.383▼ | -112.285▼ | 25.675 | 137.331▲ | -117.722▼ |
|
Friday, October 11, 2019 11:32 PM
Incyte (Nasdaq:INCY) today announces positive 52-week results from its randomized, double-blind, dose-ranging, Phase 2 study evaluating ruxolitinib cream, a nonsteroidal, anti-inflammatory, JAK ...
|
|
Monday, October 07, 2019 04:16 AM
The treatment, Bria-IMT™, has reached positive proof of concept with encouraging safety and efficacy data. BriaCell has recently entered into a collaboration with Incyte Corporation (NASDAQ:INCY) to ...
|
|
Wednesday, September 25, 2019 04:30 AM
Incyte (Nasdaq:INCY) today announced that the first patient has been treated in the Phase 3 TRuE-V clinical trial program evaluating the safety and efficacy of ruxolitinib cream as a monotherapy for ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 11/10/19 | 76.28 | 77.22 | 76.01 | 76.12 | 761,700 |
| 10/10/19 | 74.55 | 75.90 | 74.13 | 75.77 | 620,600 |
| 09/10/19 | 75.13 | 75.73 | 74.06 | 74.68 | 589,800 |
| 08/10/19 | 74.44 | 75.48 | 73.52 | 74.44 | 631,000 |
| 07/10/19 | 73.01 | 75.22 | 73.01 | 74.76 | 654,100 |
| 04/10/19 | 74.91 | 75.82 | 73.38 | 74.87 | 650,355 |
| 03/10/19 | 73.64 | 74.92 | 72.25 | 74.88 | 815,033 |
| 02/10/19 | 73.97 | 73.97 | 72.91 | 73.04 | 1,074,900 |
| 01/10/19 | 73.53 | 74.75 | 73.30 | 73.96 | 1,259,200 |
| 30/09/19 | 72.93 | 74.88 | 72.78 | 74.23 | 1,224,700 |
|
|
||||
|
|
||||
|
|